Form 4 for ALT Altimmune, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-01 · accession 0001960780-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-01 | ALT | Jordt Raymond M | Chief Business Off | M - OptEx | $0.00 | +9,375 | 45.6K | +26% | $0 |
| D | 2026-01-05 | 2026-01-01 | ALT | Jordt Raymond M | Chief Business Off | F - Tax | $3.61 | -2,475 | 43.2K | -5% | -$8,935 |
| D | 2026-01-05 | 2026-01-01 | ALT | Jordt Raymond M | Chief Business Off | M - OptEx | $0.00 | -9,375 | 9,375 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2026-01-01 | M | A | 9,375 | $0.00 | 45,645 | D | — | — | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. |
| 2 | Common | Common Stock, par value $0.0001 | 2026-01-01 | F | D | 2,475 | $3.61 | 43,170 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-01-01 | M | D | 9,375 | $0.00 | 9,375 | D | — · — to — | 9,375 Common Stock, par value $0.0001 | (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) RSUs become vested and released over four (4) years with 25% of the shares vesting on January 1, 2024, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |